ACDM News Item

Newsletter Committee: Meet Neha

Date: August 11, 2025

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee.

Neha shares the following introduction:

I am an experienced leader in Clinical Data Management with over 15 years in biotech/pharma and CRO organizations. My career has been built on driving data excellence in international clinical trials, leading cross-functional teams, and implementing innovative strategies that improve trial efficiency and data quality.

Currently, Clinical Data Management Lead at ITM, I focus on integrating advanced analytics, strengthening data governance, and ensuring regulatory compliance while fostering collaboration across clinical, medical, and regulatory teams. I am passionate about developing talent, mentoring future leaders, and promoting awareness of our profession, helping to inspire the next generation of clinical research professionals.

Made up of dedicated data management professionals, the ACDM Newsletter Committee creates engaging content that keeps members informed, connected, and up to date with ACDM activities throughout the year. Find out more about the committee here: https://acdmglobal.org/newsletter-committee/

Explore More News

Regulatory Considerations DMEG Shares Update on ICH E6(R3) Training Modules Available

The ICH Working Groups and The ICH Training Associates have released two new training . . .

Recent update from the regulatory landscape in clinical data management

On 22 September, MHRA published a new set of inspection dossier documents specifically for . . .

Regulatory Considerations DMEG Update – August 2026

Please read the following update from the Regulatory Considerations DMEG: July and . . .

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan

We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to . . .

Guidance on Decentralized Clinical Trials to be Reviewed by the ACDM RC DMEG

Health Canada (HC) continues to publish new guidelines to support their modernization of . . .

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG: Regulators have . . .

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Recent News in Regulatory Landscape

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .